• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM STEERABLE GUIDE CATHETER; VALVE REPAIR Back to Search Results
Catalog Number UNK SGC03
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Atrial Perforation (2511)
Event Date 07/02/2020
Event Type  Injury  
Manufacturer Narrative
(udi#): in the absence of a reported part number, the udi number cannot be calculated.The device remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.Article: iatrogenic atrial septal defect following the mitraclip procedure: a state-of-the-art review.
 
Event Description
This is filed to report after the mitraclip procedure, the atrial perforation had to be closed with an occulder.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with grade 4.Two clips were implanted, uncomplicated procedure.15 days later, follow-up transthoracic echocardiography (tte) showed persistent atrial septal defect (asd), mild left to right shuntdetails are listed in the article, iatrogenic atrial septal defect following the mitraclip procedure: a state-of-the-art review.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record could not be performed as lot and part number was not provided.A definitive cause for the reported patient effect of atrial perforation could not be determined in this case, however atrial perforation is listed in the mitraclip instructions for use as a known possible complication associated with mitraclip procedures.Hospitalization and additional therapy/ non-surgical treatment was a result of case-specific circumstances as the patient was treated using an amplatzer asd occluder.Although a conclusive cause for the reported patient effects and the relationship to the device, if any, cannot be determined, there is no indication of a product issue with respect to manufacture, design or labeling.D1.Removed unknown mitraclip and changed to mitraclip® system steerable guide catheter/ d2.Removed nkm and added dra.D4.Changed from unk cds to unk sgc.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM STEERABLE GUIDE CATHETER
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10422417
MDR Text Key203484408
Report Number2024168-2020-06873
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
PMA/PMN Number
K161985
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 10/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK SGC03
Date Manufacturer Received09/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
-
-